S&P Futures
5,584.00 -26.25 (-0.47%) Dow Futures
41,238.00 +60.00 (+0.15%) Nasdaq Futures
19,249.50 -166.25 (-0.86%) Russell 2000 Futures
2,199.40 +3.70 (+0.17%) Crude Oil
74.60 +0.08 (+0.11%) Gold
2,545.40 +7.60 (+0.30%)
Bio-Rad Laboratories, Inc. (BIO)
After hours:
| Previous Close | 319.37 |
| Open | 318.25 |
| Bid | 259.50 x 900 |
| Ask | 350.00 x 800 |
| Day's Range | 318.28 - 331.11 |
| 52 Week Range | 261.59 - 406.44 |
| Volume | |
| Avg. Volume | 256,882 |
| Market Cap | 8.939B |
| Beta (5Y Monthly) | 0.93 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -47.34 |
| Earnings Date | Oct 24, 2024 - Oct 28, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 360.20 |
Business WireBio-Rad’s Management to Participate in Fireside Chat During Wells Fargo’s 2024 Healthcare Conference
HERCULES, Calif., August 22, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company’s Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during Wells Fargo’s 2024 Healthcare Conference on Wednesday, September 4, at 2:15 PM Eastern Time (11:15 AM Pacific Time).
ZacksReasons to Retain Bio-Rad (BIO) Stock in Your Portfolio Now
Bio-Rad's (BIO) robust digital PCR business and Clinical Diagnostics segments raise optimism. However, macro issues raise concerns.
Business WireBio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer
HERCULES, Calif., August 20, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Jon DiVincenzo will join the company as President and Chief Operating Officer, effective September 9, 2024, replacing Andy Last, who is retiring.
